rs8133205
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001142854.2(SPATC1L):c.193+3258G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.224 in 151,960 control chromosomes in the GnomAD database, including 5,016 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.22 ( 5016 hom., cov: 32)
Consequence
SPATC1L
NM_001142854.2 intron
NM_001142854.2 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.212
Publications
16 publications found
Genes affected
SPATC1L (HGNC:1298): (spermatogenesis and centriole associated 1 like) Enables identical protein binding activity. Predicted to act upstream of or within several processes, including actin polymerization or depolymerization; positive regulation of cAMP-dependent protein kinase activity; and positive regulation of protein kinase A signaling. Predicted to be located in sperm connecting piece. Predicted to be active in centrosome. [provided by Alliance of Genome Resources, Apr 2022]
SPATC1L Gene-Disease associations (from GenCC):
- hearing loss disorderInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.409 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SPATC1L | NM_001142854.2 | c.193+3258G>A | intron_variant | Intron 2 of 4 | ENST00000291672.6 | NP_001136326.1 | ||
| SPATC1L | NM_032261.5 | c.-270+4990G>A | intron_variant | Intron 1 of 3 | NP_115637.3 | |||
| SPATC1L | XM_005261188.6 | c.193+3258G>A | intron_variant | Intron 2 of 4 | XP_005261245.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.224 AC: 34050AN: 151842Hom.: 5013 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
34050
AN:
151842
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.224 AC: 34076AN: 151960Hom.: 5016 Cov.: 32 AF XY: 0.215 AC XY: 15955AN XY: 74256 show subpopulations
GnomAD4 genome
AF:
AC:
34076
AN:
151960
Hom.:
Cov.:
32
AF XY:
AC XY:
15955
AN XY:
74256
show subpopulations
African (AFR)
AF:
AC:
17143
AN:
41390
American (AMR)
AF:
AC:
2081
AN:
15256
Ashkenazi Jewish (ASJ)
AF:
AC:
418
AN:
3468
East Asian (EAS)
AF:
AC:
5
AN:
5180
South Asian (SAS)
AF:
AC:
226
AN:
4804
European-Finnish (FIN)
AF:
AC:
1353
AN:
10552
Middle Eastern (MID)
AF:
AC:
38
AN:
294
European-Non Finnish (NFE)
AF:
AC:
12307
AN:
67996
Other (OTH)
AF:
AC:
428
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1223
2446
3669
4892
6115
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
328
656
984
1312
1640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
198
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.